This site is intended for healthcare professionals only
Dipeptidyl peptidase-4 inhibitors: the different dosing requirements of adult patients with type 2 diabetes and comorbidities
This management algorithm has been commissioned and funded by Boehringer Ingelheim Limited.
Content for healthcare professionals
Access to this content is restricted to UK-based doctors, nurses, and pharmacists
If you are a UK-based doctor, nurse, or pharmacist, you must sign in to your account or register (for free) if you do not already have one.